Menu

CG Oncology, Inc. CGON

Full chart Compare
Set alert

Price alert · CGON

All alert types
68.40 USD +3.59 (+5.55%)

Nov 6, 2026, 9:46 AM EST

66.46 Day range 69.79
35.80 52-week range 80.97
YTD
+64.73%
1 year
+72.32%

Revenue & Expenses

Other Income → Expenses: $29.78MExpenses → Gross Loss: $607.00KExpenses → Selling, General & Admin: $73.53MExpenses → Research & Development: $116.64MNet Loss → Expenses: $161.00MRevenue → Cost of Revenue: $4.04MOther Income$29.78MNet Loss$161.00MCost of Revenue$4.65MExpenses$190.77MGross Loss$607.00KSelling, General & Admin$73.53MResearch & Development$116.64MRevenue$4.04M

Latest period ending Dec 31, 2025 · select a line to chart its full history

CGON annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
4.04M1.14M204.00K191.00K10.36M
-607.00K1.14M204.00K191.00K10.36M
-190.77M-114.67M-55.45M-35.25M-12.61M
-161.00M-88.04M-48.61M-35.44M-12.84M
-2.08-1.41-15.65-11.71-5.04
CGON annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
32.49M257.07M8.27M88.14M53.61M
791.59M754.80M199.30M147.75M58.69M
38.99M21.42M14.51M22.57M18.44M
7.02M238.00K461.00K15.94M15.13M
752.60M733.38M-123.10M-77.69M-42.62M
CGON annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-132.35M-78.71M-45.68M-29.80M-13.65M
-245.82M-300.76M-121.19M-55.35M-97.00K
153.59M628.28M87.00M119.69M15.45M
-134.00K-234.00K0-14.00K-97.00K
-224.58M248.80M-79.88M34.54M1.70M